Showing results (1021-1030 of 1,339) with videos related to

Sort By:
Pageof 134
Data in Brief|July 29, 2015
Lipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticlesVellaisamy Selvaraj, Niraj Nepal, Steven Rogers, et al.
The Oncologist|June 3, 2026
Prognostic Significance of KRAS G12C Versus Non-G12C RAS Mutations in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisMohamed M Khamis, Mahsa Shirani Lapari, Omar Alkharabsheh, et al.
Data in Brief|July 29, 2015
Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsisVellaisamy Selvaraj, Niraj Nepal, Steven Rogers, et al.
Journal of Hematology & Oncology|May 31, 2011
Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancerChandrakumar Shanmugam, Robert B Hines, Nirag C Jhala, et al.
Journal of the International AIDS Society|August 8, 2017
Performance of self-reported HIV status in determining true HIV status among older adults in rural South Africa: a validation studyJulia K Rohr, F Xavier Gómez-Olivé, Molly Rosenberg, et al.
Blood Advances|May 4, 2021
CRISPR-edited megakaryocytes for rapid screening of platelet gene functionsEmilie Montenont, Seema Bhatlekar, Shancy Jacob, et al.
Journal of Hypertension|November 7, 2007
Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptorWendy W Batenburg, Manne Krop, Ingrid M Garrelds, et al.
Viruses|July 29, 2023
Added Value of Next Generation Sequencing in Characterizing the Evolution of HIV-1 Drug Resistance in Kenyan YouthVlad Novitsky, Winstone Nyandiko, Rachel Vreeman, et al.
AIDS and Behavior|August 26, 2023
Perceptions of Health, Body Size, and Nutritional Risk Factors for Obesity in People with HIV in South AfricaJennifer Manne-Goehler, Nicholas Rahim, Eva van Empel, et al.
Pilot and Feasibility Studies|June 16, 2023
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunityIsabel H Gonzalez-Bocco, Katherine Beluch, Alyssa Cho, et al.
Pageof 134